Abstract: This article deals with the recursive quadratic filtering problem for a class of linear discrete-time systems with the random access protocol (RAP) and non-Gaussian noises (NGNs). In order ...

Google launched its new video model Veo 3.1 with improved audio output, granular editing controls, and better output for image to video. It said that Veo 3.1 builds on May’s Veo 3 release and ...

In Hans Christian Andersen's folktale, The Emperor's New Clothes, when a child cries out that the emperor is naked, he isn't revealing a secret. Everyone already knows it. What changes in that instant ...

hands on Nvidia bills its long-anticipated DGX Spark as the "world's smallest AI supercomputer," and, at $3,000 to $4,000 (depending on config and OEM), you might be expecting the Arm-based mini-PC to ...

Use this iron distance chart as a benchmark. If your numbers are way off or if some clubs are all going the same distance, it may be time for a lesson or a custom iron fitting. Looking for other ...

No other artist has ever had every song from an album appear in an unbroken streak at the top of the Hot 10 — no skips. Swift had previously become the first and only artist ever to command all 10 ...

Recursion Pharmaceuticals (RXRX) saw a sharp uptick in trading as investors looked ahead to the CEO's upcoming presentation at a major AI conference. The focus is on how the company’s AI strategy and ...

Despite a 1-4 record, the Cleveland Browns remain one of the NFL’s most talked-about teams. The Browns? Not so much. One day, their rotation was led by Joe Flacco. The next, Dillon Gabriel took over.

Abstract: This article addresses the problem of secure recursive state estimation for a networked linear system, which may be vulnerable to interception of transmitted measurement data by ...

This comprehensive guide takes you from neural network fundamentals to building production-ready Tiny Recursive Models (TRMs) and other efficient small language models. Designed for junior ML/LLM ...

Recursion Pharmaceuticals trades at a $2.65bn valuation despite slow clinical progress, high cash burn, and no late-stage assets. RXRX's AI-driven drug discovery model is ambitious, but pipeline value ...

In AI research, progress is often equated with size. But a small team at Samsung’s AI lab in Montreal has taken another approach that is proving to show great promise. Their new Tiny Recursive Model ...